India pharmaceutical exports rise 4.90 per cent in first half of FY27

India’s pharmaceutical exports increased 4.90 per cent year-on-year to USD 16,135.93 million during the first half of the financial year 2026–27 (April–September 2026). This growth was supported by higher shipments of drug formulations, biologicals, bulk drugs, drug intermediates, and surgical products.

Exports to Europe rose 9.66 per cent to USD 3,288.27 million, making up 20.38 per cent of total exports. Germany, the Netherlands, and France saw double-digit increases. Namit Joshi, Chairman of Pharmexcil, said the sector should focus on innovation and higher-value segments.